GSK Nuvalent acquisition talks: FT reports talks to buy
GSK Nuvalent acquisition talks are ongoing, with no official confirmation yet and a reported deal value between $9 billion and $10 billion, per the Financial
Most important news & global events daily
GSK Nuvalent acquisition talks are ongoing, with no official confirmation yet and a reported deal value between $9 billion and $10 billion, per the Financial
EasyJet board engagement with Castlelake remains limited, as EasyJet says no discussions have occurred while Castlelake indicates it is in the early stages of
Hiab Labrie acquisition valuation suggests a Finnish-listed Hiab would acquire Labrie at an enterprise value around $1.04 billion, though formal confirmation
The focus is on a recordati takeover bid value; CVC Capital Partners’ €10.9 billion offer values Recordati, with delisting and a move to acquire remaining
The electric utilities merger potential centers on NextEra Energy Inc. in talks to acquire Dominion Energy Inc. in a largely stock deal aiming to address
KKR is reportedly exploring a sale of Flora Food Group with a potential valuation of up to $10 billion, per Financial Times reports cited by Reuters and other
India outbound deal Organon acquisition: Sun Pharma reportedly pursues a bid around $12–13 billion for Organon, with terms and final status not yet confirmed.
SBA Communications possible sale interest is being explored as part of options after preliminary takeover interest, according to people familiar with the
M A and equity markets boom: despite Iran-related tensions, M&A activity, leveraged loans, and equity capital markets are described as booming, signaling a
Wells Fargo’s reported hire of Derek Keller as managing director and head of M&A structuring signals a potential shift in deal execution capabilities, though —
Your cart is currently empty!
Notifications